VWM
IDXX icon

Vermillion Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Vermillion Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6
Closed -$3.37K – 1963
2026
Q1 		$3.37K Buy
+6
New +$3.85K ﹤0.01% 569

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vermillion Wealth Management's IDXX Position: Q2 2026 in Review

Vermillion Wealth Management sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 6 shares — an estimated $3.37K sold.

Vermillion Wealth Management first reported a position in IDXX in Q1 2026 and held it in 1 quarter. The position peaked at $3.37K in Q1 2026. 1,294 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Vermillion Wealth Management reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Vermillion Wealth Management sold 6 Idexx Laboratories shares in Q2 2026, an estimated $3.37K.
  • Vermillion Wealth Management first reported a position in Idexx Laboratories in Q1 2026 and held it in 1 quarter.
  • Vermillion Wealth Management's Idexx Laboratories position peaked at $3.37K in Q1 2026.
  • 1,294 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.